PubRank

G A Fitzgerald

Author PubWeight™ 65.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health 1947 3.44
2 Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005 3.13
3 The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol 2013 2.48
4 No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001 2.28
5 Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 1998 1.89
6 Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993 1.76
7 Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993 1.60
8 Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994 1.54
9 Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991 1.54
10 Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins 1979 1.48
11 Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 2005 1.42
12 Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 1995 1.38
13 Paracetemol poisoning--a brief report. Ir Med J 1977 1.32
14 The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther 1997 1.31
15 Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res 1980 1.15
16 Sanitation and Quality Control in the Fishery Industries. Am J Public Health Nations Health 1937 1.15
17 Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 1998 1.12
18 Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med 1992 1.11
19 Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) 1986 1.10
20 Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis 1990 1.08
21 Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol 1993 1.07
22 Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A 1989 1.04
23 Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man. Eur J Clin Invest 1980 1.04
24 Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond) 1982 1.00
25 Measurement of renal and non-renal eicosanoid synthesis. Am J Med 1986 0.99
26 Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis 1989 0.96
27 Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem 1986 0.95
28 Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med 2008 0.94
29 Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994 0.93
30 Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 1991 0.93
31 Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. J Clin Endocrinol Metab 1984 0.90
32 Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J 1993 0.89
33 Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 2000 0.89
34 Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol 1993 0.89
35 Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol 1988 0.88
36 Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther 1982 0.87
37 The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J 1998 0.86
38 Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med 1981 0.84
39 The translational therapeutics of prostaglandin inhibition in atherothrombosis. J Thromb Haemost 2009 0.83
40 Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis 1989 0.81
41 Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med 1994 0.80
42 Eicosanoid biosynthesis in human cardiovascular disease. Hum Pathol 1987 0.80
43 Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. Am J Physiol 1988 0.80
44 Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacol Bull 1994 0.79
45 Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost 2009 0.78
46 No evidence for antagonism of clonidine by naloxone in man [proceedings]. Br J Clin Pharmacol 1980 0.78
47 Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]. Br J Clin Pharmacol 1979 0.78
48 Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. Ann N Y Acad Sci 1994 0.78
49 Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost 2003 0.78
50 Histocompatibility antigens and haemochromatosis in Ireland. Ir J Med Sci 1980 0.78
51 Cellular activation of thromboxane receptors. Ann N Y Acad Sci 1994 0.77
52 Molecular cloning of the human platelet 12-lipoxygenase. Trans Assoc Am Physicians 1990 0.77
53 A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction. J Pharmacol Exp Ther 1991 0.77
54 Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clin Pharmacol Ther 2012 0.77
55 The effect of prostacyclin on pituitary hormone release. Br J Clin Pharmacol 1980 0.76
56 Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Adv Prostaglandin Thromboxane Leukot Res 1995 0.76
57 Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha. Adv Exp Med Biol 1997 0.76
58 Vovulus of the small bowel in a diabetic patient. Br Med J 1976 0.75
59 Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats. Curr Alcohol 1979 0.75
60 Prostaglandins. Ir Med J 1982 0.75
61 Antiplatelet and anticoagulant therapy during coronary thrombolysis. Trends Cardiovasc Med 2011 0.75
62 One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay. Ir Med J 1979 0.75
63 Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. Am J Physiol 1987 0.75
64 Digitoxin-quinidine interaction: potentiation during administration of cimetidine. South Med J 1981 0.75
65 Health Problems in Packing Crustacean Products. Am J Public Health Nations Health 1939 0.75
66 Cryoglobulinaemia in Henoch-Schönlein purpura. Br Med J 1977 0.75
67 Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond) 1980 0.75
68 Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man. Trans Assoc Am Physicians 1981 0.75
69 Hypertensive crisis in prazosin-treated pheochromocytoma. South Med J 1984 0.75
70 The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. Br J Clin Pharmacol 1980 0.75
71 HLA identity in juvenile onset diabetes. Ir J Med Sci 1978 0.75